Tatva Chintan Pharma Chem Limited — Results, 28-01-2025: Integrated Filing- Financial

Tatva Chintan Pharma Chem Limited has announced a board meeting to review its financial results for the quarter and nine months ended 31 December 2024. The consolidated revenue from operations stands at ₹860.69 crore, while the profit before tax for the period is reported at a loss of ₹10.93 crore. The standalone results show a similar trend with revenues at ₹839.99 crore and a net loss of ₹11.64 crore. The company remains on a positive trajectory, with no outstanding defaults on loans, positioning itself favorably for potential growth. Investor sentiment may be cautiously optimistic, given the company's solid fundamentals despite the losses.